The Hikma Court correctly held that a generic manufacturer should not be liable for induced patent infringement if it carves ...
On June 16, 2026, the Centers for Medicare & Medicaid Services (CMS) published a proposed rule that would codify the Medicare Drug Price ...
It’s time to bring production of essential medications back to the U.S. — or at least closer to home. The meeting, described ...
Federal regulators have agreed to review a Swiss pharmaceutical company's applications for two cheaper generic versions of ...
Mankind Pharma has joined forces with Denovo Sciences to revolutionize drug discovery using artificial intelligence. This ...
On June 16, 2025, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule, “Medicare Drug Price Negotiation Program and ...
The Supreme Court has unanimously ruled that generic drugmakers cannot be sued for patent infringement simply because their marketing materials don’t spell out every limitation of their FDA approval — ...
Clinical trials in China are getting attention at an international oncology gathering in Chicago. China’s surging biotechnology industry is fueling alarm that U.S. dominance in the field is waning. By ...
Evan Feinberg founded Genesis Molecular AI seven years ago to take his research at Stanford on AI for drug discovery to the real world. Today the company announced its biggest partnership to date: A ...
Ed Silverman formerly piloted The Wall Street Journal's Pharmalot blog tracking the pharmaceutical industry. His coverage included research and development, marketing, pricing, regulation, deals, ...
With questions already swirling about the actual affordability impact of the government’s drug purchasing portal, TrumpRx, the White House is updating the platform to address a key gap in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results